GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OTCPK:BVNRY) » Definitions » Cyclically Adjusted PB Ratio

Bavarian Nordic A/S (Bavarian Nordic A/S) Cyclically Adjusted PB Ratio : 2.32 (As of May. 25, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Bavarian Nordic A/S Cyclically Adjusted PB Ratio?

As of today (2024-05-25), Bavarian Nordic A/S's current share price is $8.655. Bavarian Nordic A/S's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $3.73. Bavarian Nordic A/S's Cyclically Adjusted PB Ratio for today is 2.32.

The historical rank and industry rank for Bavarian Nordic A/S's Cyclically Adjusted PB Ratio or its related term are showing as below:

BVNRY' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.81   Med: 3.51   Max: 8.59
Current: 2.31

During the past years, Bavarian Nordic A/S's highest Cyclically Adjusted PB Ratio was 8.59. The lowest was 1.81. And the median was 3.51.

BVNRY's Cyclically Adjusted PB Ratio is ranked worse than
58.04% of 653 companies
in the Biotechnology industry
Industry Median: 1.73 vs BVNRY: 2.31

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bavarian Nordic A/S's adjusted book value per share data for the three months ended in Mar. 2024 was $6.343. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.73 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bavarian Nordic A/S Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Bavarian Nordic A/S's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S Cyclically Adjusted PB Ratio Chart

Bavarian Nordic A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.19 3.97 4.97 3.28 2.38

Bavarian Nordic A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.89 2.78 2.19 2.38 1.99

Competitive Comparison of Bavarian Nordic A/S's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Bavarian Nordic A/S's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic A/S's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic A/S's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic A/S's Cyclically Adjusted PB Ratio falls into.



Bavarian Nordic A/S Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bavarian Nordic A/S's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=8.655/3.73
=2.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bavarian Nordic A/S's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bavarian Nordic A/S's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=6.343/118.4000*118.4000
=6.343

Current CPI (Mar. 2024) = 118.4000.

Bavarian Nordic A/S Quarterly Data

Book Value per Share CPI Adj_Book
201406 1.703 99.700 2.022
201409 1.540 99.700 1.829
201412 1.977 99.400 2.355
201503 1.750 100.200 2.068
201506 1.924 100.300 2.271
201509 1.857 100.200 2.194
201512 1.844 99.800 2.188
201603 1.548 100.200 1.829
201606 2.331 100.600 2.743
201609 2.426 100.200 2.867
201612 2.406 100.300 2.840
201703 2.462 101.200 2.880
201706 2.689 101.200 3.146
201709 3.484 101.800 4.052
201712 3.262 101.300 3.813
201803 3.154 101.700 3.672
201806 2.884 102.300 3.338
201809 2.910 102.400 3.365
201812 2.718 102.100 3.152
201903 2.582 102.900 2.971
201906 2.451 102.900 2.820
201909 2.277 102.900 2.620
201912 2.264 102.900 2.605
202003 4.320 103.300 4.951
202006 4.523 103.200 5.189
202009 4.763 103.500 5.449
202012 4.573 103.400 5.236
202103 4.964 104.300 5.635
202106 4.907 105.000 5.533
202109 4.759 105.800 5.326
202112 5.309 106.600 5.897
202203 4.991 109.900 5.377
202206 4.631 113.600 4.827
202209 4.373 116.400 4.448
202212 4.808 115.900 4.912
202303 5.626 117.300 5.679
202306 6.041 116.400 6.145
202309 5.727 117.400 5.776
202312 6.470 116.700 6.564
202403 6.343 118.400 6.343

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bavarian Nordic A/S  (OTCPK:BVNRY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bavarian Nordic A/S Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic A/S (Bavarian Nordic A/S) Business Description

Traded in Other Exchanges
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.

Bavarian Nordic A/S (Bavarian Nordic A/S) Headlines